• About ExoGenis

We unlock the power of biologics — without the burden of injections

We are a biotechnology delivery platform operating at the intersection of biologic delivery, clinical aesthetics, and dermatology.

ExoGenis provides a biologic-compatible, non-injectable delivery layer that enables predictable, repeatable placement of fragile biologics into viable skin — filling the gap between topical products and injectable treatments.

our mission

To enable precise, non-injectable delivery of biologics into skin by bridging the gap between topical treatments and injectable procedures.

our vision

A future where biologic therapies can be delivered locally and precisely into skin, without injections and with reduced clinical burden.

  • our team

Leadership and Scientific advisors

Irina Torres

Irina Torres

CEO & Co-founder

EMBA (LBS) - MSc, Strategy, partnerships, IP, regulatory, fundraising

Dr. Elena Tsisanova

Dr. Elena Tsisanova

CMO, Co-founder

MPharm, MSc, PhD Pharmacology, medical devices, exosomes

Linkedin Icon
Dr. Nina Tsisanova

Dr. Nina Tsisanova

Scientific advisor

Correction of age-related skin changes, treatment of vascular and pigment pathologies, and therapy for various manifestations of photo- and chronoaging

Link icon
Dr. John Ludlow

Dr. John Ludlow

Scientific advisor

Tissue engineering, cell therapeutics, regenerative medicine, and GLP/GMP process and assay development for clinical-stage products

Linkedin Icon
  • our journey

Milestones

Our technology is validated through rigorous scientific partnerships with leading research institutions.

2025

2026

01

Company founded

ExoGenis established to develop a biologic-compatible microneedle delivery platform for fragile biologics.

02

Initial research & development

Core dissolvable microneedle architecture and coating approach developed.

03

Validated prototype

Technical validation of delivery performance, stability, and controlled depth completed in Denmark.

04

Clinical pilots

Launch with select partner clinics in Europe and the UK for real-world validation.

Apply for partnership
  • Partnerships

Scientific collaborations

Our technology is validated through rigorous scientific partnerships with leading research institutions.

nnovationfonden
sono-tek logo

micro‑coating partner

zenbio-logo
nage-logo
beyound-beta-logo

Join us in shaping the future

Whether you're a potential partner, investor, or simply curious about our technology, we'd love to hear from you.

ExoGenis operates through affiliated entities, including ExoGenis ApS (Denmark) and ExoGenis Pte. Ltd. (Singapore).